tiprankstipranks

Adma Biologics sees FY25 revenue at least $490M, consensus $482.41M

Sees FY25 adjusted EBITDA at least $225M. Sees FY25 adjusted net income at least $175M.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue